Question 1

What are the current analyst recommendations for Novo Nordisk A/S?

Accepted Answer

8.33% of analysts recommend buying the stock. 37.5% recommend overweight. 45.83% recommend holding. 8.33% recommend underweight. 0 recommend selling.

Question 2

What were the most recent quarterly financial results for Novo Nordisk A/S?

Accepted Answer

In its latest quarter, Novo Nordisk A/S reported revenue of $77.52B, with earnings per share (EPS) of $6.1. These results beat market expectations.

Novo Nordisk A/S

NVO-